IGF1 and breast cancer: Renehan et al. showed that women with breast cancer without acromegaly have higher serum GH and IGF-1 levels than women without cancer, and circulating IGF-1 levels within the upper normal range have been associated with a higher risk of breast cancer in premenopausal women [26].